he Pharmacy Schools Council (PhSC) has elected Professor Katie Maddock as the organisation's new chair.
Prior to becoming head of school at Keele University, Professor Maddock had been MPharm course director and associate dean for education for the Faculty of
Medicine and Health Sciences, responsible for developing the clinical teaching at Keele.
Before joining Keele University, she taught clinical pharmacy and pharmacy practice at Aston University. Her research interests lie in pharmacy education,
particularly the use of technology in teaching, clinical therapeutics, augmented reality simulation and interprofessional education. She was also awarded a
principal fellowship of the Higher Education Academy in November 2020.
Having worked in hospital pharmacy, Professor Maddock is acutely aware of the pressures that Covid-19 has placed on healthcare, as well as the importance of
retaining and building upon the positive changes to patient care and pharmacy practice that were developed in response to the pandemic.
Boots has partnered with Uber Eats to deliver beauty essentials and healthcare products to customers' doors in 30 minutes.
Medicines for minor ailments such as coughs, colds, hay fever, mild pain, rashes as well as COVID-19 test kits can be ordered through Uber Eats.
Boots is partnering with the doorstep delivery company with a pilot in 14 of its stores around the UK, with 13 of those stores giving customers within range
access to third-party doorstep delivery of Boots products for the very first time.
Uber Eats customers within range of participating Boots stores can choose from more than 900 products available for delivery straight to their homes or workplace,
including toiletries, medicines for minor ailments, food and drink options, and best-selling beauty and gifting options perfect for a last-minute gift or treat.
Paula Bobbett, Chief Digital Officer at Boots said: "We are hugely excited to be launching our partnership with Uber Eats. As the first health and beauty retailer
on its platform, we can offer an extensive range of product options to customers for delivery straight to their door. Whether it's medicines for mild illnesses or
last-minute gifts, beauty items or top-ups of a favourite skincare brand, we can meet all our customers' needs both quickly and conveniently."
A group of pharmacists on Saturday (July 2) took part in this year's Pride in London parade, as the annual LGBTQ+ celebration returned to the capital after
three years due to the Covid-19 pandemic.
Those who participated in the march called on the government to ban conversion therapy for all LGBT+ people, reform the Gender Recognition Act, and provide equal
protection for LGBT+ communities against hate crime.
The event which drew a crowd of a million people marked the 50th anniversary since the first ever parade in London in 1972.
Amandeep Doll, head of professional belonging at RPS, said: "It was a privilege to join in the recognition of the diversity of the LGBTQI+ community and our
profession, especially on such a historic occasion. Our group of pharmacists and allies from all parts of the country loved the excitement and buzz of the day."
All pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies, clarified the Company
Chemists' Association (CCA) in response to an attack by the Pharmacists' Defence Association.
Last week, PDA allegedly accused some large pharmacy chains of 'orchestrating' full or part-time closures of some of their shops due to the staff shortage.
In its Open Letter published on Tuesday (July 19), PDA demanded urgent action "to protect patients by ensuring that essential community pharmacy services are
provided safely and consistently".
"All parts of the healthcare system are struggling to recruit staff and to assume that pharmacies would be immune to such pressures, seems fanciful," said CCA.
"CCA members are working extraordinarily hard to prevent temporary closures, but recruitment and retention of pharmacists is becoming increasingly tough. The recent
rise in Covid cases and the beginning of the summer holiday season in parts of the UK have only worsened the situation."
The Association also showed data from the PSNC Pharmacy Pressures Survey (April 2022) which found that 91 per cent of pharmacies are experiencing staff shortages,
clearly demonstrating that these shortages are affecting the entire sector.
The Association of the British Pharmaceutical Industry (ABPI) has appointed Susan Rienow, country president of Pfizer, as its vice president.
"As vice president, she will support the president, Pinder Sahota, general manager and corporate vice president of Novo Nordisk UK, in delivering his priorities.
These are improving access to medicines, delivering economic growth and helping to find solutions to big societal challenges such as climate change, AMR, and
inequalities," said ABPI in a statement.
At Pfizer, Susan leads the organisation to bring the power of innovation, data and technology together to transform healthcare and improve outcomes for patients.
She previously led Pfizer UK's vaccines business unit during the Covid-19 pandemic.
Hobbs, who joined the company in 2019, navigated it through the challenges of the COVID-19 pandemic, and successfully oversaw the acquisition and integration
of Lexon in 2023. He will retire from the company at the end of September 2024.
"After five years with the company, I am retiring at the end of September to spend time with my wife who was diagnosed with motor neurone disease last year," Hobbs
said.
"I wish to extend my personal thanks to our owners, the Bestway Group, for their kindness and understanding of our situation.
"It has been a privilege to lead the Well Pharmacy, now Bestway Healthcare organisation. The business is resilient for today and fit to prosper in the long term.
When I leave it will be with gratitude and admiration for the 7,500+ people in Bestway Healthcare who are committed to improving the lives of our patients and
customers, thank you all."
AstraZeneca said its antibody cocktail against Covid-19 would - unlike its vaccine - be priced commercially as it negotiates supply contracts with governments around the globe.
"We are looking at a commercial pricing strategy. That is part of our negotiations with governments," Iskra Reic, Astra's executive vice president for vaccines and immune therapies, said in a media call on Thursday.
She added that the group's main objective was to make the shot affordable and broadly available.
To support NHS, clear the backlog created by the Covid-19 pandemic and help community pharmacies support more people, the Welsh government has announced an allocation of further £12.5 million funding.
Of the total amount, £10mn will be distributed across the 22 local authorities to buy equipment to help people to live independently in their own homes post hospital stay.
The remainder, £2.5mn, will be used to support community pharmacists and patients to improve access to treatment and advice for a range of common ailments.
The move is aimed at alleviating waiting times and reducing winter pressures on the NHS.
Commenting on the announcement, Elen Jones, Royal Pharmaceutical Society director for Wales said: "We are delighted that the Welsh government continue to recognise the value of pharmacists in patient care and we welcome this additional investment and support for Community Pharmacy teams across Wales.
Community pharmacies in England will continue to receive the free protective equipment (PPE) as the Government's scheme has been extended for another year until
March 2024.
The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social
care staff according to demand until the end of March 2024, or when stocks run out.
Last year, DHSC implemented a new and improved portal platform for eligible providers to access free COVID-19 related PPE supplies.
The Pharmaceutical Services Negotiating Commitee (PSNC) said: "Community pharmacy teams can continue to order PPE from the NHS PPE portal for free for as long as
stock is available."
The Royal Pharmaceutical Society (RPS) has decided to lease two floors of its east London headquarters to Ingeus, a business with services in employment, health, justice and youth.
RPS will retain three floors of the building, including its museum and library on the ground floor, as well as the two upper floors which will be used for events, collaborative working and team meetings.
The decision follows an announcement in April that the the Society was re-evaluating whether it needed to hold on to its current office space as homeworking was becoming the norm due to the Covid-19 pandemic. The Society also wanted to maximise value from its property and generate additional revenue which could "be
reinvested into further developing our valued products and services".
Ingeus runs the government-sponsored Restart Scheme to help people find jobs in their local area.
Three leading pharmacists - professor Mahendra Patel, Asif Aziz and Ade Williams - have been recognised in Queen Elizabeth's annual New Year's honours list.
Professor Patel, an academic pharmacist from West Yorkshire, was awarded an OBE for his "services to pharmacy." He told Pharmacy Business: "I am truly honoured and deeply humbled by this highly prestigious award that I have always believed was more deserving for others.
"That's not to say I'm not proud of it - far from it, although for me it's not necessarily about rewards and recognition but more the intricacies of the journey I embark on and the learning and joy that those encounters bring with it.
Most recently, Professor Patel - who has had a broad ranging portfolio career spanning community pharmacy, health education and health promotion, academia, and research - has been involved in promoting clinical trials across community pharmacies in the UK.
His latest work has seen him act as one of the national leads for the PRINCIPLE and PANORAMIC trials, run by Oxford University - both trials seek to pioneer repurposed and new drug treatments in the community to prevent hospitalisation due to Covid-19.
New mask mandates and other measures aimed at curbing the spread of the Omicron coronavirus variant came into England today, as Prime Minister Boris Johnson eyes an expanded booster programme to help increase protection against Covid-19.
From Tuesday morning (November 30), face masks are compulsory on transport and in shops, banks and hair salons.
All international travellers must take a PCR test by the end of the second day after they arrive, and self-isolate until they get their result. That is in addition to restrictions on arrivals from 10 southern African countries, who have to enter hotel quarantine.
Britain has reported 11 cases of the Omicron variant so far, and while the government says this number will rise, it says it is important to slow its spread until more is known about the variant's transmissibility and impact on vaccines.
NHS cancer check has set a new record, despite pressures on hospitals due to Covid-19, the number of people being treated for the cancer remained higher than
before the pandemic, revealed NHS.
Over the last 12 months almost three million people were referred for cancer checks which is up by over a tenth on the 2.4 million people referred before the
pandemic.
"Even at the peak of the Omicron wave, referrals for suspected cancer were at 116 per cent of pre-pandemic levels with around 11,000 people getting checked every
day over the last year," said NHS.
In order to meet increasing demand for cancer checks, NHS services across the country are expanding their diagnostic capabilities through one stop shops for tests,
mobile clinics and cancer symptom hotlines, ensuring people are diagnosed and treated as early as possible to give them a much better chance of beating the disease.
More than 30,000 people every month are being invited for lung cancer checks through NHS mobile trucks visiting at risk communities across the country, as part of
the biggest programme to improve early lung cancer diagnosis in health service history.
In his maiden speech delivered to community pharmacy since becoming new minister with responsibility for the sector, Will Quince MP said he's determined to be
"your champion" and "voice in government".
Addressing delegates on Wednesday (Oct 12) as chief guest at the 22nd Pharmacy Business Awards in central London, he praised community pharmacy for delivering 25
million Covid-19 vaccines, five million flu jabs, 200 million lateral flow testing kits and millions of medicines throughout the pandemic.
"These local efforts became the national success story," he told over 600 attendees at a gala dinner held at the iconic Park Plaza Westminster Bridge hotel
overlooking the Houses of Parliament.
'We need you now'
Quince, who was appointed minister of state at the Department of Health and Social Care on 7 September 2022, added: "Just as we needed you in the pandemic, we
need you now," highlighting the vital role of community pharmacy in realising the secretary of state (Thérèse Coffey)'s vision, particularly in regard to her
much talked about 'Plan for Patients'.
Amid the ongoing furore over shortages of Lateral Flow Device (LFD) test kits that led pharmacy staff to bear customers' wrath, the National Pharmacy Association (NPA) and Company Chemists Association (CCA) have jointly appealed the public to be "patient and courteous to pharmacy teams".
In an open letter, the two organisations have urged patients and customers to be patient, courteous and safe while visiting their local pharmacies.
Highlighting the efforts put in by healthcare workers to keep everyone safe through this tough winter, the two organisations said the pressure of Covid-19 and shortage of LFD kits have sometimes led to verbal abuse of pharmacy staff.
Mark Lyonette, NPA chief executive said: "The vast majority of pharmacy customers and patients are polite and understanding. The supply situation with Lateral Flow Tests is stretching people's patience, but that's no excuse for abusive behaviour and people need to understand the constraints on pharmacy teams at this time."
Alongside their routine job of providing medicines, health advice and a range of NHS services, pharmacies have put in extra effort to protect people during the pandemic.
Walgreens Boots Alliance has announced the launch of its new clinical trials business that aims to use patient data from its pharmacies to help drive up
recruitment in studies conducted by drugmakers.
With patient recruitment and enrollment remain key challenges in clinical trials, further exacerbated by the COVID-19 pandemic, the company said it can proactively
match diverse patient populations to trials across a range of disease areas based on race, gender, socioeconomic status and location with its patient reach and
access to an extensive foundation of pharmacy and patient-authorised clinical data.
The Boots owner also believes that by leveraging a tech-enabled approach to patient identification and creating a large registry of clinical trial participants,
the company will be able to reduce the time it takes to match eligible patients to clinical trials.
"Walgreens trusted community presence across the nation, combined with our enterprise-wide data and health capabilities, enables us to pioneer a comprehensive
solution that makes health options, including clinical trials, more accessible, convenient and equitable," said Ramita Tandon, chief clinical trials officer,
Walgreens.
Following centuries of stigma, the importance of mental wellness is finally matching that of physical healthcare.
Conditions such as depression have become common topics in the media, particularly in the last few years as celebrities and experts warned against the pressures of
social media. The bouts of isolation connected with the Covid-19 pandemic exacerbated the issue, with the British Medical Association declaring a UK mental health
crisis at the end of 2022.
This media attention has led to acknowledgement of the realities of mental health problems from the government and medical sector, and a recognition that these
need to be approached differently to physical ailments when it comes to providing treatment.
If you are motivated to be involved in this rapidly changing industry, consider these rewarding business ideas for developing a career in mental health.
Become a counsellor
Counselling is a broad term, but essentially it is the practice of having impartial conversation with patients about their life experiences with a view to overcoming
emotional obstacles and trauma. Training can take three to five years depending on whether you are getting a degree or diploma, and there are many opportunities to
specialise both during and after your education.
Psychotherapy is a similar field, but this is a more academically focused course that tends to be concerned with long-term or particularly complex mental health
issues. You will need a post-graduate qualification and several years of training to become certified.
Reacting to recommendations from a UK-first independent review, the Department of Health and Social Care (DHSC) has outlined action to tackle potential
bias in the design and use of medical devices.
Professor Dame Margaret Whitehead, professor of public health at the University of Liverpool, was appointed to lead the review, which focused on three
areas - optical devices such as pulse oximeters, AI-enabled devices, and polygenic risk scores (PRS) in genomics.
The DHSC commissioned the medical devices review after concerns were raised that pulse oximeters - widely used during the COVID-19 pandemic to monitor blood
oxygen levels - were not as accurate for patients with darker skin tones. There were worries that this could cause delays in treatment if dangerously low oxygen
levels in such patients were missed.
However, no evidence was found from NHS studies indicating that this differing performance had an impact on patient care.
Accepting the report's conclusions, the DHSC has committed to several actions, such as ensuring the safe use of pulse oximeter devices across a range of skin
tones within the NHS and eliminating racial bias from data sets employed in clinical studies.
The government will on Thursday launch a drive to boost childhood vaccination rates, health authorities said, seeking an "urgent reversal" to a fall in
uptake as the country faces a worsening measles outbreak.
Routine childhood immunisations in Britain for diseases including measles, mumps and rubella, diphtheria and polio, have been falling gradually over the past
decade, but dipped more sharply after the Covid-19 pandemic, mirroring a global decline.
Last year UNICEF said people worldwide had lost confidence in the importance of routine childhood vaccines during the pandemic, with misinformation, dwindling
trust in governments and political polarisation contributing to rising hesitancy.
Britons will begin seeing adverts from next week across various media, including a television campaign featuring children reminding parents of the risk of missing
out on vaccinations, the UK Health Security Agency (UKHSA) said.
"We need an urgent reversal of the decline in the uptake of childhood vaccinations to protect our communities," UKHSA chief executive Jenny Harries said in a
statement.
The Galien Foundation recently announced the winners of the 2024 Prix Galien UK Awards, with the University of Oxford receiving accolades for its
groundbreaking contributions to public sector innovation through the PRINCIPLE and PANORAMIC Trials.
These trials, spearheaded by Oxford's team of experts, have set a new standard for scientific innovation aimed at improving global health outcomes.
Led by University of Oxford, the PRINCIPLE and PANORAMIC Trials epitomize a remarkable collaboration aimed at combating the COVID-19 pandemic.